Ann-Charlotte Kristoffersson
21 – 40 of 41
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy.
(
- Contribution to journal › Article
- 2012
-
Mark
A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
(
- Contribution to journal › Article
-
Mark
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis
(
- Contribution to journal › Article
-
Mark
Intestinal damage in enterohemorrhagic Escherichia coli infection.
(
- Contribution to journal › Article
-
Mark
IgA nephropathy associated with a novel N-terminal mutation in factor H.
(
- Contribution to journal › Article
- 2010
-
Mark
Intestinal Damage in Enterohemorrhagic Escherichia coli (EHEC) Infection
2010) 15th Congress of the International Pediatric Nephrology Association In Pediatric Nephrology 25(9). p.1834-1834(
- Contribution to journal › Published meeting abstract
-
Mark
ADAMTS13 Expression in Glomerular Endothelial Cells
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
A novel mutation in the complement regulator clusterin in recurrent haemolytic uraemic syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients.
(
- Contribution to journal › Article
-
Mark
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
(
- Contribution to journal › Article
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
- 2007
-
Mark
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
(
- Contribution to journal › Article
-
Mark
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
-
Mark
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
(
- Contribution to journal › Article
- 2006
-
Mark
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Platelet activation in hemolytic uremic syndrome.
(
- Contribution to journal › Scientific review
- 2005
-
Mark
VWF-cleaving protease (ADAMTS13) in premature infants.
(
- Contribution to journal › Article
- 1996
-
Mark
Recurrent mutation Asn45-->Ser of glycoprotein IX in Bernard-Soulier syndrome
(
- Contribution to journal › Letter